THURSDAY, March 14, 2019 -- Young Americans may be more vulnerable to depression, distress and suicidal thoughts or attempts than their parents' generation, and social media might be fueling that troubling trend.
So claims a review of a decade's worth of data on roughly 200,000 teens between the ages of 12 and 17, and 400,000 young adults over 18.
WEDNESDAY, March 6, 2019 -- The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine -- a relative of the club drug and anesthetic ketamine -- for use against severe depression.
Sold as Spravato, the fast-acting drug becomes the first new type of medicine approved in years against an illness that plagues millions of Americans.
TUESDAY, Jan. 15, 2019 -- People who develop type 2 diabetes before they turn 40 are twice as likely to be hospitalized for mental illness as those who develop the blood sugar disease after 40, a new study shows.
About 37 percent of all hospitalization days in the under 40 group were due to mental illness, the researchers noted. Mood and psychotic disorders were the most common conditions. Mood disorders includes depression, bipolar depression and self-harm. Psychotic disorders include delusions, hallucinations and schizophrenia, according to the U.S. Department of Health and Human Services.
MONDAY, Feb. 4, 2019 -- Certain bacteria dwelling in the human gut might feed depression, according to a new study that adds evidence to the theory.
Researchers found that among over 2,100 adults, those with depression showed differences in specific groups of gut bacteria. And people with higher concentrations of certain other gut bugs generally reported better mental well-being.